Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Child Welfare topic

No spam. Unsubscribe anytime.

DCYF: after a 2025 spike, early 2026 shows drop in child-welfare critical incidents

Substance Use Recovery Services Advisory Committee · August 3, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Assistant Secretary Vicky Ybarra told the advisory committee that Washington saw a record rise in DCYF-defined critical incidents in 2025 but a sharp decline in the first quarter of 2026; DCYF is planning SB 6109–funded prevention pilots in nine high-need communities starting Jan. 2027.

Vicky Ybarra, Assistant Secretary for Partnership Prevention and Services at the Department of Children, Youth and Families, briefed the Substance Use Recovery Services Advisory Committee on the agency’s definition of critical incidents and recent trends. She said DCYF counts child fatalities and near-fatalities that are maltreatment-related and involve prior DCYF contact in the past 12 months.

"In 2025, we saw a record number of critical incidents," Ybarra said, noting that earlier years typically showed about 20–25 such incidents annually. She told the committee that the first quarter of 2026 included seven critical incidents (four fatalities and three near‑fatalities), a decline the agency described as more than a 60% drop from the previous quarter.

Ybarra attributed the change to multiple factors: decreases in opioid-overdose responses reported on the state DOH dashboard, wider availability of medications for opioid use disorder and harm‑reduction tools, expanded internal DCYF practices (including statewide safe child consults and more youth-and-family meetings), and a statutory change under Senate Bill 6109 that clarified how courts should treat the presence of high‑potency synthetic opioids when considering removal.

Committee members asked what measures DCYF used to assess SB 6109’s impact. Ybarra said the observation was not a formal research analysis: "There was no quantitative data analysis other than the observation that the increase in entries into care" coincided with legal and practice changes. She added DCYF and research partners (RDA) produce recurring reports and that more detailed SUD-treatment work‑group findings will follow.

Ybarra also described a typology DCYF uses to prioritize prevention services: substance‑exposed infants and toddlers (including accidental ingestion tied to unsafe sleep), high‑need frequently encountered families who cycle through front‑end responses without court filing, and a smaller group of medically complex children with intensive care needs. She said DCYF has identified nine high‑need communities to invite applications for SB 6109‑funded pilots and aims to implement services in January 2027.

DCYF committed to providing written follow‑up answers to specific measurement questions and said the agency is coordinating with DOH and HCA on training and communications related to changing drug‑scheduling and treatment access.